DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 802 filers reported holding DANAHER CORPORATION in Q3 2013. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,986,923 | +3.3% | 88,621 | -0.1% | 2.03% | +2.2% |
| Q2 2023 | $21,290,923 | -5.1% | 88,712 | -0.3% | 1.99% | -11.7% |
| Q1 2023 | $22,433,332 | -5.3% | 89,007 | -0.2% | 2.25% | -11.0% |
| Q4 2022 | $23,681,600 | +0.9% | 89,223 | -1.8% | 2.53% | -3.2% |
| Q3 2022 | $23,475,000 | +1.6% | 90,885 | -0.3% | 2.61% | +7.1% |
| Q2 2022 | $23,100,000 | -13.4% | 91,117 | +0.2% | 2.44% | +3.4% |
| Q1 2022 | $26,682,000 | -13.8% | 90,963 | -3.3% | 2.36% | -4.0% |
| Q4 2021 | $30,952,000 | +8.3% | 94,076 | +0.2% | 2.45% | -0.4% |
| Q3 2021 | $28,573,000 | +11.7% | 93,853 | -1.5% | 2.46% | +13.0% |
| Q2 2021 | $25,576,000 | +10.3% | 95,304 | -0.1% | 2.18% | +8.5% |
| Q1 2021 | $23,191,000 | +8.2% | 95,415 | -1.1% | 2.01% | -1.6% |
| Q4 2020 | $21,434,000 | +2.2% | 96,490 | -1.0% | 2.04% | -10.4% |
| Q3 2020 | $20,977,000 | +11.5% | 97,416 | -8.5% | 2.28% | -16.2% |
| Q2 2020 | $18,821,000 | +27.7% | 106,433 | -0.0% | 2.72% | +6.9% |
| Q1 2020 | $14,735,000 | -10.1% | 106,459 | -0.3% | 2.54% | +8.6% |
| Q4 2019 | $16,395,000 | +5.5% | 106,823 | -0.7% | 2.34% | -1.3% |
| Q3 2019 | $15,542,000 | +4.0% | 107,607 | +2.9% | 2.37% | -0.1% |
| Q2 2019 | $14,945,000 | +5.6% | 104,568 | -2.4% | 2.37% | +7.1% |
| Q1 2019 | $14,146,000 | +28.4% | 107,153 | +0.3% | 2.22% | +12.6% |
| Q4 2018 | $11,016,000 | +1.3% | 106,825 | +6.8% | 1.97% | +19.9% |
| Q3 2018 | $10,871,000 | +11.6% | 100,049 | +1.4% | 1.64% | +3.1% |
| Q2 2018 | $9,740,000 | +2.8% | 98,698 | +2.0% | 1.59% | -0.9% |
| Q1 2018 | $9,471,000 | +8.0% | 96,727 | +2.4% | 1.61% | +7.5% |
| Q4 2017 | $8,769,000 | +9.0% | 94,477 | +0.7% | 1.49% | +3.8% |
| Q3 2017 | $8,046,000 | -6.5% | 93,798 | -8.0% | 1.44% | -2.5% |
| Q2 2017 | $8,605,000 | +13.8% | 101,962 | +12.3% | 1.48% | +1.7% |
| Q1 2017 | $7,564,000 | +9.3% | 90,768 | +2.1% | 1.45% | +0.8% |
| Q4 2016 | $6,920,000 | +5.0% | 88,901 | +5.7% | 1.44% | -9.4% |
| Q3 2016 | $6,590,000 | -25.0% | 84,069 | -3.4% | 1.59% | -17.7% |
| Q2 2016 | $8,790,000 | +11.8% | 87,031 | +5.0% | 1.93% | -8.9% |
| Q1 2016 | $7,862,000 | -0.5% | 82,875 | -2.6% | 2.12% | +18.5% |
| Q4 2015 | $7,901,000 | +8.4% | 85,069 | -0.5% | 1.79% | +4.1% |
| Q3 2015 | $7,286,000 | +1.7% | 85,502 | +2.2% | 1.72% | +10.2% |
| Q2 2015 | $7,162,000 | +1.6% | 83,674 | +0.8% | 1.56% | -1.2% |
| Q1 2015 | $7,046,000 | +3.0% | 82,993 | +3.9% | 1.58% | +0.9% |
| Q4 2014 | $6,844,000 | +15.0% | 79,846 | +2.0% | 1.57% | +9.7% |
| Q3 2014 | $5,950,000 | -4.1% | 78,311 | -0.6% | 1.43% | -4.6% |
| Q2 2014 | $6,203,000 | +5.7% | 78,787 | +0.7% | 1.50% | +0.4% |
| Q1 2014 | $5,868,000 | +1.0% | 78,234 | +3.9% | 1.49% | -4.4% |
| Q4 2013 | $5,811,000 | +13.0% | 75,266 | +1.5% | 1.56% | +2.5% |
| Q3 2013 | $5,143,000 | +10.9% | 74,185 | +1.2% | 1.52% | +5.3% |
| Q2 2013 | $4,638,000 | – | 73,270 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |